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Seroprevalence Of HBV,HCV and HIV Viruses among Blood  
Donors in Al- Mukalla – Hadhramout- Yemen 
 




This Retrospective study was done during the year 2009  to determine the seroprevalence of  hepatitis B virus (HBV), 
hepatitis C virus (HCV) and human immunodeficiency virus (HIV), among blood donors in Al-Mukalla hospitals 
blood banks – Hadhramout-Yemen. Data was collected from blood banks, recorded and grouped according to their 
serology results. A total of 4526 blood donors were registered  during the study period.  252 of them (5.3%) were 
hepatitis B surface antigen (HBsAg) positive, 29 (0.6%) were anti-hepatitis C virus (anti- HCV) positive  and 4 
(0.09%) were- anti- human immunodeficiency virus(Anti- HIV) positive. Their average age was between 18 -50 
years, and all positive cases were males. The seroprevalence rate of positive hepatitis B surface antigen (HBsAg) 
among blood donors was intermediate in relations to other  areas in our country but higher than worldwide except 
African countries. Anti-HCV among this sample was lower than other areas in our country and similar in being low if 
compared to international findings. Anti-HIV  was low and similar to regional and Asian countries. 
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Introduction: 
The discovery of transfusion-transmissible 
infections (TTIs) has heralded a new era in blood 
transfusion practice worldwide with emphasis on 
two fundamental objectives, safety and 
protection of human life. Hepatitis C virus 
(HCV), human immunodeficiency virus(HIV) 
and hepatitis B virus (HBV) are the three most 
important agents responsible for transfusion 
transmitted infections (TTIs) [28]. The risk of 
transmitting hepatitis through transfusions of 
blood and blood products has been known since 
1950 (28). In 1965, Blumberg reported  the 
discovery of the hepatitis B surface antigen 
(HBsAg) [28]. Hepatitis B virus (HBV) is the 
most common cause of serious liver infection in 
the world and is said to have infected more than 
two billion people [26].  
The World Health Organization (WHO) reported 
that approximately 350 million people are 
chronically infected with the hepatitis B virus 
and 170 million people carry the hepatitis C virus 
worldwide [20]. The hepatitis C virus was 
discovered in 1989 as the major causative agent 
of non A and non B hepatitis (3). The hepatitis C 
virus is transmitted via blood and blood products, 
both parenterally and through sexual contact [3].  
The first case of transfusion-associated AIDS 




cases were reported all over the world in which 
transfusion of blood and its products was the 
only risk factor [33,41].
 
Acquired  
immunodeficiency syndrome (AIDS) is the 
leading universal health problem of considerable 
socioeconomic  impact. In 2005, the  United 
Nations Program reported that 40.3 million   
people  are living with AIDS, of which 7.4 
million in East and Southeast Asia [42]. 
However,  some countries reported low levels of 
HIV epidemic such as in Afghanistan, Egypt, 
Iraq, Jordan, Lebanon, Libya, Morocco, 
Palestine, Qatar, Saudi Arabia, Syria, Tunisia, 
United Arab Emirates and Yemen (44). 
However, limited biological supervision of  HIV 
infection  may not reflect the true prevalence 
among the populations in these countries [44]. 
With every unit of blood, there is 1% chance of 




infections, HIV and hepatitis are the most 
dreadful (9). The improved screening and testing 
of blood donors has significantly reduced 
transfusion-transmitted diseases in most 
developed countries (9). Poor health education 
and lack of awareness result in the reservoir of 
infections in the population. 
The present study has been conducted to screen 
the HIV, HBV and HCV in blood donors at the 
blood bank units of Ibn-Sina and Al- Mukalla 
hospitals in Al- Mukalla city- capital of 
Hadhramout governorate.  
 
Materials and methods: 
This descriptive retrospective study was done 
among blood donors that attend blood banks in 
Ibn-Sina general hospital and Al-Mukalla 
hospital for childhood and maternity in Al-
Mukalla city –Hadhramout at a period of January 
to December 2009. These hospitals are the two 
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only governmental  tertiary level teaching 
hospitals that provides health services to people 
in  Mukalla city and all Hadhramout and nearby 
governorates. 
Blood donors were either volunteers, or relatives 
or friends of recipient patients. All of them were 
Yemeni nationality. Data was collected from 
blood banks records, and donors were grouped 
according to serology results.  
Inclusion Criteria: Apparently healthy donors of 
age 18 to 50 years with body weight above 45 kg 
would qualify for donation.  
Exclusion Criteria: Individuals with anemia or 
past history of jaundice as well as those with a 
last blood donation not exceeding 4 months were 
excluded. Female donors don't accepted if 
pregnant or nursing or had a menstrual cycle.   
In the blood banks, the first step in screening for 
potential blood donors was taking age and past 
medical history of the client. Individuals were 
required to give answers to questions on previous 
illnesses and medical conditions, and past history 
of blood transfusion, but there is no written 
logbook. For that, there were no information 
about age, residency, occupation and blood 
grouping of donors.  
ELISA tests were used for investigation of 
HbsAg, anti-HBc and anti-HIV antibodies. 




During the period of year 2009, 4526 individuals 
visited Ibn-Sina and Al-Mukalla hospitals for 
donation of blood. The age of donors range from 
18 to 50 years old and almost all of them were 
volunteers, relatives or friends of recipient 
patients. The Majority of donors were males 
(4523, 99.93%) and only 3 donors (0.07%) were 
females (Table 1). 
 
Table (1) Distribution of blood donors according to sex 
 
Gender Frequency Percent 
Male 4523 99.93 
Female 3 0.07 
Total 4526 100 
 
After going through the process of  screening, it 
was found that 252 (5.6%) were suffering from 
HBV infection and all of them were males.  A 
total of 29 (0.6%) donors were infected with 
HCV and 4 of them (0.09%) were positive for 
HIV all of them were males. (Table 2).
 
Table(2): Prevalence of positive antibodies against HBV, HCV and HIV in all Blood donors study 
 
HIV(n&%) HCV(n&%) HBV (n&%) Results 
4 (0.09) 29(0.6) 252(5.6) Positive 
4522(99.91) 4497(99.4) 4274(94.4) Negative 
4526(100) 4526(100) 4526(100) Total 
 
The  seroprevalence  of  HBV,  HCV and  HIV is 
purely among male blood donors included in this 
study, and no positive cases for HbsAg, anti-HBc 




In this study an attempt had been made to define 
the seroprevalence of Hepatitis B, C and HIV 
among healthy donor population mostly from 
Hadhramout and nearby governorates. Data 
consists of analysis of one year (January to 
December 2009). 
In this study, 4526 individuals were investigated 
for HBV, HCV and HIV; Most of them were 
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males. This is due to low hemoglobin level  in 
females in our community and the fact that 
women are less willing to donate blood due to 
cultural aspects  in the community. The high 
ratio of male to female blood donors in Yemen 
was similar to other countries [8,16,23]. The 3 
female donors in this study were donated blood 
due to a rare blood grouping (2 cases) or an 
emergency requirement of blood in absence of 
male donors (1 cases). 
The study showed that the seroprevalence of 
HBV among blood donors in Al-Mukalla city  
hospitals was as high as 5.3%. This result had 
similar rate or less than other studies conducted 
in different cities in our country such as in Aden 
(5.1%) [7], Taiz (7%) [31], Hajja (9.8%) [19] 
(Fig. 1) and another study done by collecting 
data from different governorates (10.8%) [12], 
whereas lower rates were found in other studies 
done in Al-Hodeida (2.35%) [34] and Sana 




Fig.1: Prevalence of HBV and HCV in different cities in our country. 
 
In the other hand, the seroprevalence of HBV 
was higher compared to many other countries. In 
regional and Arab countries, the rate in multiple 
studies done in different places in Saudi Arabia 
were (1.5%, 1.82% and 2.34%) [6,13,16,34], in 
Emirates was (0.23%) [5], Qatar (0.9%) [17], 
Iraq (4%) [8] and in Egypt (1.4%, 2.1%) [38,43]. 
In Asian countries HBV prevalence was also 
lower than our study as in Iran (0.56% - 3.74%) 
[10,22],  India (1.7%, 2.23%) [11,32], but lower 
or similar to our study in Pakistan 
(2.28%,3.3%,5.96%) [23,24,25], and in Thailand 
(4.61%) [27].  
In African countries seroprevalence was variable, 
higher as in Nigeria (7.50%) [37], and similar to 
this study as in Ethiopia (4.7%) [40]. In Turkey, 
the prevalence was lower than our study at some 
studies (1.38%,1.76%) [1,2] but higher in other 
study (4.19%) [18]. In other western and 
developed countries, the prevalence is much 
lower as in Germany (1.6%) [30], Canada 
(0.124%) [14], and America (0.0756 %) 
[15],Table (3). 
The seroprevalence rates of hepatitis B were high 
in Al-Mukalla. It was intermediate to other cities 
in our countries and high in relation to other 
countries except African countries. Transmission 
of hepatitis B through unscreened blood 
transfusion, and reuse of unsterilized syringes 
and medical equipment are well documented in 
the pertinent literature. Moreover, people having 
cupping, history of dental treatment, 
circumcision and shaving by barbers are also at 
increased risk due to reuse of equipment. 
We found that 0.6% of the blood donors were 
positive for anti - HCV. This rate was the lower 
rate in the Republic of Yemen. A higher rate was  
seen in other studies among blood donors in our 
country which reported that Anti-HCV were 
about (0.79%) of the blood donors in Al-Hodeida 
[35], (1%) in Taiz [31], (1.1%) in Hajja [19], 
(1.3%) in Aden [7], (3%) in Sana [4] (Fig1), and 
(2.7%) in other meta-analysis study performed in 
different governorates in Yemen during the 
period 2000-2005 [12]. Comparing to regional 
and Arab countries; the rates were somewhat 
similar to different studies in Saudi Arabia (0.4% 
-0.59% %) [13,16,34], but lower rate in Emirates 
(0.11%) [5], and higher rates in Qatar (1.39%) 
[17], Iraq (1%) [8] and Egypt (3.5% -7.1% ) 
[38,43]. 
In Asian countries the seroprevalence was also 
variable comparing to our study from lower 
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prevalence in India (0.66%-1.0%) [11,32], low to 
higher prevalence in Pakistan (0.07% -4.0%) 
[23,24,25], to higher prevalence in Thailand 
(2.90%) [27]. In African countries e.g. Ethiopia 
and Nigeria, the prevalence was somewhat 
similar to slight higher than our study (0.7%) 
(0.96%) [37,40]. In contrast, the prevalence in 
developed countries was lower than our study 
like Turkey (0.07%- 0.38%) [1,2,18], Germany 
(0.00002%) [30], Canada (0.1683%) [14], and 
America (0.299%) [15] Table (3). 
 
Table (3): Prevalence of HBV and HCV in different countries comparing to our   study 
 
Country HBV prevalence % HCV prevalence % 
Al-Mukalla-Yemen 5.30 0.60 
Saudi Arabia 1.5-2.34 0.4- 0.59 
Emirates 0.23 0.11 
Qatar 0.90 1.39 
Iraq 4.00 1 
Egypt 1.4-2.1 3.5-7.1 
Iran 0.56 - 3.74 0.12 
India 1.7-2.23 0.66-1 
Pakistan 2.23-5.96 0.07- 4 
Thailand 4.61 2.90 
Nigeria 7.50 0.70 
Ethiopia 4.70 0.96 
Turkey 1.38- 4.19 0.7-038 
 
The seroprevalence of anti-HCV in Al-Mukalla 
was low in comparing with other cities in the 
Republic and most other countries despite the 
same transmission route as HBV which shows 
high prevalence and there is no clear explanation 
for that. 
HIV infection rate among blood donors in this 
study was low (0.09%), in comparison with other 
studies in Al-Hodeida-Yemen (0.14) [35] , Sana-
Yemen (0.39%) [36], Makah in Saudi Arabia 
(0.12%)[34], India (0.3%, 0.56%) [11,32], 
Thailand (0.69%) [27], Ethiopia (3.8%) [40], 
Kenya (2-20%) [29] and Nigeria (0.96%) [37], 
but higher than that reported in Emirates 
(0.004%) [5], Iran (0.004%) [10], Pakistan 
(0.007%, 0.02%) [13,23], Turkey (0.008%) [1], 
Canada (0.00038%) [14], America (0.0097%) 
[15] and Germany (0.000018%) [30].  
The seroprevalence of  HIV among blood donors 
in Al-Mukalla is low and it is going with low 
prevalence in the region despite high contact of 
Yemeni people with people from African 
countries where HIV transmission risk is high. 
There are however some shortcomings in our 
study, one of these is the absence of 
classifications of donors to age groups, and the 
other is lack of blood grouping of donors, and 
this is due to the absence of related information 
from the blood banks. 
  
Conclusion: 
Among blood donors that were screened, the 
seroprevalence of hepatitis B was much higher in 
Al-Mukalla and in our country, where HCV has 
a similar - low prevalence comparing to most of 
countries worldwide. HIV has low prevalence of 
all blood borne viruses among blood donors. 
Given the lack of information on the prevalence 
of hepatitis B, C  and HIV in the general 
population in Yemen, we recommend a 
population based study for the assessment of 
hepatitis B, C and HIV prevalence as a first step 
to implement control measures. 
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 مدى االنتشار املصلي لعدوى التهاب الكبد "بي" و "سي" وفريوس نقص املناعة 
 اليمن –يف مدينه املكال  البشري بني املتربعني بالدم
 




لبيان مدى فيروسات الكبد الوبائي "بي" و" سي" وفيروس نقص المناعة المكتسبة بين المتبرعين بالدم في  2116أجريت الدراسة خالل العام  
وشممت  حضرموت. تم جمع المعمومات من سجالت بنوك الدم , وتم تقسيم المتبرعين  حسب نتائج فحوصاتهم المصمية, -مدينة المكال
يجابية لفيروس الكبد إ%( 2.5حالة ) 222ال. وكانت منهم لى بنوك الدم بمستشفيات مدينة المكإبالدم الذين حضروا   اً متبرع 1223الدراسة 
سنة  21-45ت بين عمار الحاالألفيروس نقص المناعة البشري. كان %( 1.16حاالت) 1%( لفيروس الكبد "سي" و1.3حالة ) 26"بي" و
خرى في اليمن أة مع مناطق ابم" في المتبرعين بالدم متوسطا مقيجابية فيروس الكبد "بيإان معدل . كاً يجابية كانت ذكور إلت اوكل الحاال
مناطق مع ال بالمقابمةولكنها كانت عالية بالنسبة لدول المنطقة ودول العالم باستثناء الدول األفريقية. أما فيروس الكبد " سي" فكان منخفضا 
لبقية بمدان المنطقة والبمدان لى مماثل لبقية البمدان. فيروس نقص المناعة المكتسب كان منخفضا أو مماثال إي بالدنا و منخفض األخرى ف
 سيوية. ألا
 فيروس الكبد "بي", فيروس الكبد "سي" , فيروس نقص المناعة البشري, المتبرعون بالدم, المكال.الكممات المفتاحية: 
 
